title: Chemerin and cardiovascular risk in rheumatoid arthritis after interleukin 6 receptor blockade.
authors: First Department of Propaedeutic/Internal Medicine, University of Athens Medical School, Laiko General Hospital, Athens, Greece; kmakrila@med.uoa.gr.
authors: Konstantinos
authors: K
authors: Makrilakis
authors: First Department of Propaedeutic/Internal Medicine, University of Athens Medical School, Laiko General Hospital, Athens, Greece;
authors: Kalliopi
authors: K
authors: Fragiadaki
authors: First Department of Propaedeutic/Internal Medicine, University of Athens Medical School, Laiko General Hospital, Athens, Greece;
authors: Petros P
authors: PP
authors: Sfikakis
authors: Dudley Group National Health Institutes Foundation Trust, Dudley, and Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, UK.
authors: George D
authors: GD
authors: Kitas
mesh_terms: D001172:Arthritis, Rheumatoid / Q000097:blood*; D050197:Atherosclerosis / Q000097:blood*; D002318:Cardiovascular Diseases / Q000097:blood*; D002340:Carotid Artery Diseases / Q000097:blood*; D018925:Chemokines / Q000097:blood*; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male
chemical_list: D018925:Chemokines; D036341:Intercellular Signaling Peptides and Proteins; C478630:RARRES2 protein, human